For example, experiments can be carefully designed to investigate the effect of CDK4/CDK6 inhibitors in treating Subtype_2 cancer patients using in vitro cancer cell line model, ex vivo or in vivo cancer models. This evidence concerns the gene CDK6 and cancer.